Global 2-Hexyldecanol Market to Reach USD 111 Billion by 2032, Driven by Cosmetic Industry Growth

 

The global 2-hexyldecanol market, valued at USD 75 billion in 2022, is poised for significant growth, projected to reach USD 111 billion by 2032. This anticipated expansion, driven by a CAGR of 4% over the forecast period, is largely attributed to increasing demand in the cosmetics industry. As more low-income countries experience growth in their cosmetics sectors, the demand for 2-hexyldecanol, a key ingredient in many personal care products, is expected to rise.

This upward trend in the 2-hexyldecanol market reflects broader economic shifts and increasing consumer spending on personal care in emerging economies. The versatile nature of 2-hexyldecanol, which is used for its emollient and conditioning properties, makes it a valuable component in various formulations, thereby fueling its market demand. With the cosmetics industry expanding globally, particularly in developing regions, the market for 2-hexyldecanol is set to experience robust growth in the coming decade.

Connect with Our Sales Team Now to Explore the In-Depth Insights in This Report and Drive Your Business Forward.

Key Driving Factors:

  1. Surging Demand in End-Use Industries:
    • 2-Hexyldecanol finds extensive applications in industries such as cosmetics, pharmaceuticals, and personal care products. The increasing demand for these end-use products contributes significantly to the growth of the 2-hexyldecanol market.
  2. Cosmetic and Personal Care Industry Expansion:
    • The cosmetic and personal care industry is a major consumer of 2-hexyldecanol. The compound is valued for its emollient properties, enhancing the texture and feel of cosmetic formulations. As the global population becomes more conscious of personal grooming and appearance, the demand for cosmetics and personal care products continues to rise.
  3. Pharmaceutical Applications:
    • 2-Hexyldecanol serves as an essential ingredient in certain pharmaceutical formulations. Its utility in drug delivery systems and topical formulations contributes to its increased adoption in the pharmaceutical industry. As healthcare needs grow worldwide, the demand for pharmaceuticals is expected to rise, positively impacting the 2-Hexyldecanol market.
  4. Growth in Emerging Economies:
    • Emerging economies are witnessing rapid industrialization and urbanization, leading to an increased demand for consumer goods, cosmetics, and pharmaceuticals. The 2-hexyldecanol market benefits from this trend as manufacturers cater to the rising needs of these expanding markets.
  5. Research and Development Initiatives:
    • Ongoing research and development activities focus on exploring new applications and improving the production processes of 2-hexyldecanol. Innovations in formulations and applications are likely to open up new avenues for market growth.
  6. Stringent Regulatory Environment:
    • Stringent regulations in the cosmetic, personal care, and pharmaceutical industries regarding the use of safe and effective ingredients have boosted the demand for high-quality compounds like 2-hexyldecanol. Compliance with these regulations ensures a steady market for the compound.

Key Companies Profiled in the 2-Hexyldecanol Market

  • BASF SE
  • Sasol Ltd
  • Kisco Ltd
  • New Japan Chemical Co., Ltd
  • DowPol Corporation
  • Jarchem Industries Inc
  • TCI AMERICA
  • Merck KGaA

Complete Market Review: A Full Report Analysis

Key Segments Profiled in the 2-Hexyldecanol Market 

By Grade:

  • Technical Grade
  • Pharma Grade

By Function:

  • Solvent
  • Emulsifier
  • Solubilizer
  • Others

By End Use:

  • Personal Care & Cosmetics
  • Pharmaceuticals
  • Polymer & plastics
  • Dyes
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of ~400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Gigabit Passive Optical Network Market to be Worth USD 11,688.9 Million by 2033: Future Market Insights, Inc.

The global gigabit passive optical network (GPON) market size is anticipated to surpass a valuation of USD 6,821.7 million in 2023. It is anticipated to hit a valuation of USD 11,688.9 million by 2033. The market is poised to record a modest CAGR of 5.5% from 2023 to 2033.

Manufacturers of GPON equipment are providing contemporary OLTs as a way to enhance network infrastructure. All of these elements are promoting OLT growth in the GPON market. The demand for fiber optic signal conversion to PON frequencies and frames has further fueled OLT market expansion.

The need for OLTs in the GPON market has increased as a result of the rise in data, voice, and video traffic streaming over international networks. Since OLTs can reduce network costs and simplify the infrastructure without sacrificing performance, they are anticipated to have a substantial influence on GPON industry growth.

Get in Touch with Our Sales Experts Now and Gain the Insights You Need to Thrive!

The market expansion of the optical network terminal (OLT) has been influenced by the expanding necessity to manage the information flow across optical distribution networks in both directions. The global deployment of fiber-optic network access by OLTs has fueled growth in the GPONs industry.

Key Takeaways from the Gigabit Passive Optical Network Market

  • In 2018, the global GPON market size stood at US$ 5,732.6 million.
  • The market size recorded US$ 6,565.6 million in 2022.
  • The market developed at a CAGR of 3.4% from 2018 to 2022.
  • In 2022, the optical line terminal segment by component accounted for 56.6% of the share in the global market.
  • In 2022, the telecommunications segment by vertical garnered 20.4% market share.
  • In 2022, the United States accounted for 16.7% of the share in the global market.
  • In 2022, the United Kingdom market captured a 4.3% share of the global market.
  • In 2022, China held a 3.7% share of the global GPON market.
  • In 2022, Japan held 5.8% market shares globally.

Leading Key Players:

  • Huawei
  • Cisco
  • ZTE
  • Nokia
  • Calix
  • FiberHome
  • DASAN Zhone
  • Allied Telesis
  • ADTRAN
  • Iskratel
  • Alphion
  • Unizyx
  • Others

Recent Developments in Gigabit Passive Optical Network (GPON) Market:

  • To offer consumers and companies throughout the world high-speed symmetrical 10G services, Calix, Inc. has announced that over 225 broadband service providers (BSPs) are actively establishing Calix XGS-PON networks. With the Intelligent Access EDGE based on the AXOS® Network Innovation Platform, BSPs can now streamline the management of their networks and speed up the deployment of fiber. With Calix Operations Cloud, BSPs may automate operations and anticipate maintenance needs in addition to real-time network health monitoring and machine learning.
  • AirFiber Networks’ fiber extension was powered by Nokia’s GPON technology in May 2021. This business upgraded its network and introduced high-speed data services with the aid of a broadband solution to better serve its clients. Within a year, AirFiber Network expects to be able to provide broadband services to 100,000 users in India by putting the solution into practice.
  • Global Connect purchased fiber-based single-dwelling unit (SDU) assets from Telenor Sweden and its wholesale business Open Universe in November 2021. A total of 14,000 houses on Telenor’s SDU fiber network and about 200,000 linked homes on Open Universe’s platform are expected to be acquired by Telenor Sweden as part of the deal. GlobalConnect wants to leverage the deal to bridge Sweden’s digital gap.

A Full Report Analysis:
https://www.futuremarketinsights.com/reports/gigabit-passive-optical-network-market

GPON Market Segmentation:

By Component:

  • Optical Line Terminal
  • Optical Network Terminal

By Technology:

  • 2.5G Pon
  • XG-Pon
  • XGS-Pon
  • NG-PON2

By Application:

  • Fiber to the Home (FTTH)
  • Fiber to the Building (FTTB)
  • Fiber to the Curb (FTTC)
  • Fiber to the Node (FTTN)
  • Mobile Backhaul

By Vertical:

  • Transportation
  • Telecommunications
  • Healthcare
  • Energy & Utilities
  • Residential (MTU)
  • Commercial Industries

By Services:

  • Fixed Internet and Voice
  • Internet Protocol TV (IPTV)
  • Mobile Voice and Internet

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Progesterone Market Set for Remarkable Growth: Projected to Reach USD 4.80 Billion by 2034

 The global progesterone market is poised for significant expansion over the next decade, according to extensive research. Projected to grow at a healthy Compound Annual Growth Rate (CAGR) of 12.30% from 2024 to 2034, the market is anticipated to rise from its preliminary valuation of USD 1.50 billion in 2024 to an impressive USD 4.80 billion by 2034.

The surge in the progesterone market is driven by the increasing prevalence of critical health conditions such as breast cancer, AIDS, and amenorrhea. Progesterone’s pivotal role in treating these issues is a key factor contributing to the market’s upward trajectory. Researchers have highlighted the efficacy of progesterone, especially when combined with estradiol, in regulating various medical disorders, including human immunodeficiency virus (HIV).

Checkout Now to Access Industry Insights

According to the World Health Organization reports in 2021, around 38.4 million people were infected with HIV. For breast cancer treatment, hormone therapy is constrained to cases that show the prevalence of receptors for progesterone and estrogen.

The progesterone and estrogen market envisions higher growth opportunities because of the surging investments and the research and development practices of private research establishments and government institutions to reveal better usages of hormone therapy. There are diverse ongoing investigations to evaluate the influence of progesterone in postmenopausal women.

The progesterone industry witnesses growth constraints because of the side effects encountered after its treatment. Some prevalent side effects are weight fluctuations, increased face and body hair, headache, persistent breast tenderness, and baldness. Though these symptoms do not seem grave, yet they can become serious if the progesterone treatment is not done in a disciplined and experienced environment.

Regional Outlook:

North America is slated to garner a considerable share of the progesterone market, because of the amplifying resilience of modern treatments. A catalyst to the growth is the foresighted approach of progesterone vendors, who are undertaking joint efforts to strengthen their research and development abilities. This strategy is in response to the escalating demand for progesterone, which is spurred by the high disease burden, such as rising cases of kidney, and breast cancer and a soaring population of menopausal women.

“The progesterone demand is slated to witness growth owing to spurring demand from health protection sectors worldwide. Factors like soaring consciousness of women’s health and development in pharmaceuticals strengthen progesterone market expansion.”, says an FMI analyst.

Key Takeaways:

  • The natural segment in the formulation category is set to grab a share of 62.00% in 2024.
  • In the route of administration category, the injectable segment is set to acquire a market share of 38.20% in 2024.
  • The United States progesterone industry implies augmentation at a CAGR of 12.60% between 2024 and 2034.
  • The United Kingdom progesterone market indicates a CAGR of 13.70% through 2034.
  • Chinese market infers a CAGR of 13.20% through 2034.
  • Japan’s sale of progesterone indicates a CAGR of 14.10% through 2034.
  • South Korean progesterone market reflects expansion between 2024 and 2034 at a CAGR of 14.70%.

Competitive Landscape:

Prominent progesterone vendors are striving to dominate the market. The industry is set to experience a considerable upsurge in integrated progesterone companies and an amplified presence for regional brands, booming their market share. The progesterone providers adopt novel technologies, research and development, and expansions to augment their position.

Latest Evolutions:

  • In September 2022, the Scottish Medicines Consortium commenced the usage of BIJUVE (1mg Estradiol/100mg Progesterone) across the NHS. Theramex’s Bijuve® is the first body-identical hormone replacement therapy (HRT) signified for estrogen insufficiency traits in postmenopausal women.
  • In May 2023, the FDA sanctioned Veozah, a drug made to curb symptoms like flushing and sweating undergone by women with low estrogen levels.

Gain a Competitive Edge with the Insights from Our Full Report

Key Market Players:

  • Alkem Laboratories Ltd
  • Aquatic Group
  • Bionpharma Inc.
  • Cadila Pharmaceuticals
  • Cipla Inc.

Key Segments:

By Formulation:

  • Natural
  • Synthetic

By Route of Administration:

  • Injectable
  • Oral
  • Transdermal
  • Other

By Application:

  • Menopause
  • Contraception
  • Dysfunctional Uterine Bleeding
  • Hyperplastic Precursor Lesions
  • Endometrial Cancer
  • Other

By Drug Type:

  • Branded
  • Generic

By Type:

  • Prescription
  • OTC

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Functional Dyspepsia Drug Market Poised for Robust Growth, Projected to Reach USD 16.4 Billion by 2034

The global functional dyspepsia drug market is set to experience significant expansion, with an anticipated valuation of USD 10.3 billion in 2024. This growth trajectory is largely driven by the increasing geriatric population, a key factor contributing to the rising prevalence of functional dyspepsia worldwide. According to recent forecasts, the market is expected to witness a robust compound annual growth rate (CAGR) of 4.8% over the next decade, reaching an estimated USD 16.4 billion by 2034.

The dynamic landscape of the functional dyspepsia drug market is characterized by strategic collaborations between pharmaceutical companies, academic institutions, and research organizations. These partnerships are crucial in fostering innovation and accelerating the development of effective treatments for functional dyspepsia. Joint research efforts are not only expediting the discovery of novel therapeutic targets but also facilitating the translation of scientific advancements into clinical applications.

Checkout Now to Access Industry Forecasts

Growing acceptance and utilization of complementary and alternative medicine approaches, such as herbal remedies, acupuncture, and mind body therapies, create opportunities for the development of natural or herbal based pharmacological treatments.

Investments in healthcare infrastructure, including the establishment of specialized gastrointestinal clinics and endoscopy centers, improve access to diagnostic services and specialist care for patients with functional dyspepsia. The infrastructure development supports the diagnosis and management of the condition, fuelling the market growth.

Harmonization of regulatory standards and the establishment of expedited approval pathways for gastrointestinal drugs across different regions streamline the drug development process.

It also facilitates market entry, encouraging investment in functional dyspepsia drug development. Research into the role of gut microbiota in gastrointestinal health has led to interest in developing drugs that modulate the microbiome to alleviate functional dyspepsia symptoms.

Probiotics, prebiotics, and fecal microbiota transplantation are areas of exploration, offering potential for novel treatment options. Advancements in regenerative medicine, including tissue engineering and stem cell therapies, offer potential for tissue repair and regeneration in gastrointestinal disorders like functional dyspepsia.

Regenerative approaches may provide long term therapeutic benefits and address underlying pathologies. Emphasis on patient reported outcomes and patient preferences in drug development processes promotes the development of drugs that align with patient needs and preferences.

Patient centric approaches enhance treatment satisfaction, adherence, and overall healthcare outcomes. The digitization of healthcare records and the widespread adoption of electronic health record systems facilitate data sharing and real time monitoring of patient outcomes.

Key Takeaways from the Market Study:

  • Global functional dyspepsia drug market was valued at USD 7 billion in 2023.
  • From 2019 to 2023, the market demand expanded at a CAGR of 6.5%.
  • The market in Korea to expand at a CAGR of 7.0% through 2034.
  • By indication, the functional dyspepsia segment to account for a CAGR of 4.6% through 2034.
  • The market in China will expand at a CAGR of 5.5% through 2034.
  • In terms of channel, the over the counter segment to account for a CAGR of 4.4% through 2034.

“EHR integration with decision support tools enhances clinical decision making and improves the management of functional dyspepsia,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).

Competitive Landscape:

The functional dyspepsia drug market is characterized by a diverse array of pharmaceutical companies, research institutions, and healthcare organizations striving to develop and commercialize innovative treatments for functional dyspepsia.

Company Portfolio:

  • Salix Pharmaceuticals, Inc. specializes in developing and commercializing gastrointestinal therapeutics for conditions such as functional dyspepsia. The company offers a range of products targeting different aspects of gastrointestinal health, including medications for symptom relief and disease management.
  • Abbott Laboratories is a diversified healthcare company with a presence in various therapeutic areas, including gastroenterology. Abbott offers medications such as proton pump inhibitors, antacids, and digestive enzyme supplements.

Instant Report Access – Empower Your Strategy with Key Insights

Key Companies Profiled:

  • Takeda Pharmaceutical Company Limited
  • AstraZeneca plc
  • Salix Pharmaceuticals Inc.
  • Abbott Laboratories
  • Pfizer Inc.
  • Sanofi SA
  • Procter & Gamble
  • Haleon plc
  • ANI Pharmaceuticals, Inc.
  • Dr. Reddy’s Laboratories Ltd.

Segmentation Analysis of the Functional Dyspepsia Drug Market:

By Indication:

  • Functional Dyspepsia
  • Organic Dyspepsia

By Drug Type:

  • Proton Pump Inhibitors
  • H-2-Receptor Antagonists
  • Antacids
  • Antibiotics
  • Prokinetics
  • Antidepressants

By Medication:

  • Branded Medicine
  • Generic Medicine

By Channel:

  • Over the Counter
  • Prescription

By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Luer Lock Connector Market Poised for Moderate Growth, Reaching USD 2,361.4 Million by 2034

As per the latest industry analysis by Future Market Insights (FMI), the global luer lock connector market, which was valued at approximately USD 1,713.8 million in 2023, is set to exhibit steady growth over the next decade. With a projected Compound Annual Growth Rate (CAGR) of 3.3%, the market value is expected to increase from USD 1,769.0 million in 2024 to an impressive USD 2,361.4 million by 2034.

Luer lock connectors, essential components of medical devices, play a crucial role in minimally invasive procedures such as intravenous therapy and drug delivery systems. Their widespread compatibility and ease of use have spurred innovation and adoption in new medical devices, driving market expansion globally.

To Available Checkout on Report, Click

Luer lock connectors are vital for preventing contamination and fluid leaks, enhancing patient safety, and reducing healthcare-related infections. The luer lock connector market is further growing due to rising investments in emerging regions and changes in healthcare infrastructure.

The integration of luer IV connectors into electronic medical records (EMRs), pumps, and other medical devices is made possible by advances in connection technology. These innovations are being widely embraced by healthcare professionals in both developed and developing countries, contributing to the growth of the luer lock connector market.

Key Takeaways from the Market Study:

  • The global luer lock connector market is estimated to grow at a CAGR of 3.3% by 2034.
  • The United States is set to rise at a CAGR of 2.1% by 2034.
  • By 2034, India is projected to surge at a CAGR of 5.8%.
  • Based on the configuration, the Y-channel segment is set to grow at 3.4% CAGR by 2034.
  • By fluid displacement, the positive displacement segment is projected to rise at a CAGR of 3.8% by 2034.

“Smart luer lock connectors with sensors or RFID/NFC tags are gaining popularity in healthcare for remote monitoring of drug delivery, infusion rates, and patient compliance. Specialized connectors for oncology, anesthesia, and newborn care are also gaining traction due to specific clinical requirements and niche markets, offering various sizes, shapes, and material compositions.” –says a Future Market Insights (FMI) lead analyst.

Competitive Landscape:

To introduce new products, key companies in the market are placing a greater emphasis on research and development initiatives. Leading manufacturers are concentrating on executing certain strategic initiatives, such as mergers and acquisitions, business development, and new product introductions.

For instance,

  • In December 2023, B. Braun Medical Inc. launched CARESITE Micro™ Luer Access Device and Extension Sets to inflate their product portfolio.
  • In Sept. 2023, Progressive Medical, Inc., a prominent distributor of specialized medical products, collaborated with Asset Medical to introduce various infusion therapy products with diverse options and advanced features.

Elevate Your Business Game – Get the Full Report Instantly

Key Companies Profiled:

  • VYGON
  • ICU Medical
  • BD
  • Baxter
  • B. Braun SE
  • CODAN Companies
  • NP Medical
  • ASSET MEDICAL
  • AdvaCare Pharma
  • IndoSurgicals Private Limited.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Amsino International, Inc.
  • JCM MED
  • LILY MEDICAL CORPORATION
  • BAIHE MEDICAL EUROPE
  • Nexus Medical
  • Hangzhou Fushan Medical Appliances Co., LTD.

Key Market Segments:

By Configurations:

  • Straight Channel
  • T-Channel
  • Y-Channel
  • Others

By Fluid Displacement:

  • Positive Displacement
  • Negative Displacement
  • Neutral Displacement

By Luer Connector Type:

  • Male
  • Female

By End-user:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Maternity Centers
  • Long Term Care Facilities
  • Home Healthcare Settings
  • Emergency Service Providers
  • Blood Banks
  • Others

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia and Pacific
  • Western Europe
  • Eastern Europe
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

According to FMI Smart Space Market Size, Forecast, Analysis and Share Surpass USD 69,125.6 Million | 2034, At 16.2% CAGR

The smart space market is expected to be valued at USD 15,459.8 million in 2024. The market is expected to progress at an astonishing rate over the forecast period, with a CAGR of 16.2%. By 2034, the value of the market is forecast to reach USD 69,125.6 Million.

Both office and residential spaces are transforming into smart spaces at a positive rate. With technology infiltrating an increase in daily aspects for people, smart spaces are becoming a more common phenomenon, both for working and for living. While smart spaces are typically associated with economically well-off nations, developing countries are also making efforts to transform their cities into smart spaces.

Get in Touch with Our Sales Experts Now and Gain the Insights You Need to Thrive!

The government’s drive to build smart cities is helping the market. Local authorities of urban areas are concentrating on developing smart spaces as a way of dealing with the ever-increasing settling of people into cities. The desire of people to live in smart buildings and homes is also driving the adoption of smart spaces.

Smart spaces are helping businesses to track compliances as well as maximize profit. For example, energy management and optimization assist organizations in complying with mandated rules while also cutting down on costs. For public bodies, security, and infrastructure development are primary concerns that smart spaces help with.

Key Takeaways from the Smart Space Market Report:

  • The smart space market is anticipated to be valued at USD 15,459.8 million in 2024.
  • Hardware is a popular component of smart spaces. For 2024, hardware is expected to contribute to 45.3% of the market share.
  • Energy management and optimization is the leader in the application segment. For 2024, energy management and optimization is expected to contribute to 23.9% of the share.
  • Australia is one of the promising countries in the market. The CAGR for Australia over the forecast period is anticipated to be 19.7%.
  • Japan is poised to be one of the most lucrative Asian countries in the market. For the 2024 to 2034 period, the CAGR for Japan is pegged at 17.4%.

Competition Analysis of the Smart Space Market

Market players commonly partner with public authorities interested in developing smart cities. The market is fragmented, with healthy competition abounding.

Leading Key Players:

  • Cisco
  • Siemens
  • Huawei Technologies
  • IBM

A Detailed Full Report:
https://www.futuremarketinsights.com/reports/smart-spaces-market

Recent Developments in the Smart Space Market

  • In January 2024, the King Abdullah Financial District Development and Management Co. and the Saudi Co. for Artificial Intelligence formed a partnership to develop smart traffic solutions in Riyadh.
  • In November 2023, Thales Alenia Space announced plans to open a smart factory in Rome.

Smart Space Market Segmentation:

By Component:

  • Hardware
  • Software
  • Solutions

By Application:

  • Energy Management and Optimization
  • Emergency Management
  • Security Management
  • Others

By Premises Type:

  • Commercial
  • Residential
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

United States & Europe EndoAVF Device Industry Poised for Steady Growth, Projected to Reach USD 118.3 Million by 2034

According to the latest analysis by Future Market Insights, the United States and Europe EndoAVF device market is set to experience robust growth over the next decade. The industry, valued at USD 85.1 million in 2024, is expected to register a steady Compound Annual Growth Rate (CAGR) of 3.3%, reaching USD 118.3 million by 2034.

The rising demand for single-catheter systems is a significant driver behind this growth, with sales anticipated to surge at a CAGR of 3.4%. Single-catheter systems have gained widespread adoption in healthcare facilities due to their simpler design and ease of use compared to dual-catheter systems. These systems enable healthcare professionals to handle and navigate endovascular procedures more efficiently, enhancing patient outcomes and procedural success rates.

Checkout Now to Access Actionable Insights

Multiple factors are set to propel demand for EndoAVF devices across the United States and Europe through 2034. These include a growing incidence of end-stage renal disease (ESRD) and an escalating preference for minimally invasive procedures like EndoAVF.

In 2018, the prevalence of ESKD was 242 per million in the United States. This figure is anticipated to increase further due to rise in diabetes, hypertension, glomerulonephritis, and cystic kidney disease, creating growth prospects for EndoAVF device industry.

Today, both patients and healthcare professionals are showing a preference for minimally invasive procedures like EndoAVF. This is due to side effects associated with conventional surgical procedures. Courtesy of this, demand for EndoAVF devices is set to grow steadily across the United States and Europe.

Key Takeaways from the Report:

  • The United States & Europe EndoAVF device industry is set to total USD 118.3 million by 2034.
  • Based on product, single-catheter system demand is forecast to rise at 4% CAGR through 2034.
  • By technology, thermal resistance held an 1% value share in 2024.
  • By end-user, the hospital segment will record a CAGR of 6% from 2024 to 2034.
  • The United States industry value is predicted to total USD 52.54 million in 2024.
  • Demand in Germany is set to grow at 2% CAGR through 2034.

“Spike in kidney diseases and growing preference for minimally invasive surgeries are anticipated to fuel growth of the EndoAVF device industry in the United States and Europe through 2034,” says a lead analyst of Future Market Insights (FMI).

Who is Winning?

Leading EndoAVF device manufacturers are focusing on new product launches and approvals to stay ahead of the competition. They are establishing new research and development facilities to develop innovative EndoAVF solutions. Various companies are employing strategies like mergers, partnerships, and distribution agreements.

Recent Developments:

  • In June 2023, BD strengthened its manufacturing ability with the inauguration of a €4 million research and development facility in Blackrock, Dublin. It also invested €30 million to strengthen its manufacturing facility in Enniscorthy, Wexford.
  • In February 2019, BD received 510(k) approval from the U.S. Food and Drug Administration for their BD WavelinQ 4 French (4F) EndoAVF system.

Unleash Strategic Potential Get the Complete Report Here

Key Companies Profiled:

  • BD
  • Medtronic Plc

Industry Segmentation:

By Product:

  • Single-catheter system
  • Dual-catheter system

By Technology:

  • Thermal Resistance
  • Radiofrequency Pulse

By End-user:

  • Hospitals
  • Ambulatory Surgical Centers
  • Dialysis Centers

By Country:

  • United States
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Thermal Interface Materials Market Projected to Reach USD 6,413.3 Million by 2033 with a CAGR of 11.5%

Thermal Interface Materials Market
Thermal Interface Materials Market

Between 2023 and 2033, the global market for thermal interface materials is anticipated to grow at a compound annual growth rate (CAGR) of 11.5%. According to forecasts, the market will be valued at USD 2,159.4 million in 2023 and USD 6,413.3 million by 2033.

Throughout the forecast period, the demand for thermal interface materials is anticipated to be driven by the rising need for automation in pharmaceuticals and medical equipment production.

Also, as the prevalence of illnesses and disorders among people in both rich and emerging economies rises, so does the need for medications and medical items. Global sales of thermal interface materials are likely to increase as a result.

Consumer electronics frequently use thermal interface materials to enhance performance, sustainability, quality, functionality, and environmental attributes. Due to their great protection & durability, these materials contribute to an increase in the lifespan of consumer electronics. Moreover, it is predicted that the market is supported by the rising need for thermal conductivity in high-end electronic devices.

Key Takeaways

  • By 2033, the thermal interface materials market in the United Kingdom is likely to expand, with a CAGR of 4.4%.
  • In 2023, the United States is expected to develop the thermal interface materials business with a share of 25.5%.
  • The thermal interface materials market grew considerably to US$ 2,005 million in 2022.
  • The thermal interface materials sector expanded at a CAGR of 3.1% from 2018 to 2022.
  • By 2033, China’s thermal interface materials market is projected to develop with a CAGR of 10.8%.
  • By 2033, India’s thermal interface materials industry is projected to expand with a CAGR of 11.7%.
  • Japan’s thermal interface materials industry is likely to grow significantly, with a 4% share in 2023.
  • Australia’s thermal interface materials sector is likely to expand with a share of 1.3% in 2023.
  • Germany’s thermal interface materials business is expected to grow, with a share of 12.2% in 2023.
  • In 2023, grease and adhesives are expected to dominate the market, with a share of 35.7%, based on the product type.
  • In 2023, the computer segment is expected to dominate the market, with a share of 25.1%, based on application.

Contact Our Sales Team Now to Discuss How You Can Acquire This Report and Gain Valuable Insights for Your Business.

Competitors Winning Strategies

Numerous small- and large-scale producers are prevalent in the global market. To accommodate the value chain component of their firm, the companies have thought about diversifying and integrating their business operations. The businesses are attempting to maintain their position as market leaders by taking advantage of economies of scale and growing through acquisitions and mergers. Companies are using mergers and acquisitions to increase the scope of their product offerings and boost product quality.

Recent Development:

  • Dow Corning Company introduced the DOWSIL TC-4040 TIMs in June 2022. This gap filler has good heat conductivity, is simple to use, and doesn’t droop. Introducing this new product aids the company’s ability to compete in the TIMs industry.
  • Loctite EA 9536 magnet bonding tape, which offers high materials expansion for electric motors, was introduced by Henkel AG & Co. KGaA in April 2020. With the help of an epoxy-based adhesive film, the magnet is fixed firmly in place, gaps are filled, and the electric motor’s manufacturing tolerances are considered.

Key players

  • 3M Company
  • Henkel
  • Indium Corporation
  • Fujipoly]
  • The Dow Chemical Company
  • Honeywell International Inc.
  • SIBELCO
  • Shin-Etsu
  • Ray Techniques

Comprehensive Industry Report: A Full Market Analysis

Key Segments

By Product Type:

  • Tapes and films
  • Elastomeric Pads
  • Greases and adhesives
  • Phase change materials
  • Metal-Based
  • Others

By Application:

  • Telecom
  • Computer
  • Medical devices
  • Industrial machinery
  • Consumer durables
  • Automotive electronics
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of ~400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

IoT in Manufacturing Market is Expected to See a Growth of 14.7% CAGR through 2033 | Future Market Insights, Inc.

The IoT in manufacturing market is projected to have a market share of USD 948.6 billion by 2033 while it is likely to be valued at USD 265.2 billion in 2023. The market is estimated to grow at a steady CAGR of 14.7% over the forecast period.

The limited amount of malfunction and its early detection along with the capability of IoT that senses temperature, voltage, and vibration is making it more useful to industrial operations.

The increased satisfaction through IoT and connected devices is enhancing the productivity and efficiency of the manufacturing units, allowing them to work on their maximum capabilities

Updated client calls, improved asset management, and higher customer care service are also some key factors that IoT technology delivers to manufacturing units.

Get in Touch with Our Sales Experts Now and Gain the Insights You Need to Thrive!

The IoT deployment also makes the whole work affordable as it allows companies to cut on labor expenditure and implements operational intelligence. Furthermore, the higher popularity of this advanced technological addition fuels market growth.

The advanced addition of artificial intelligence with IoT creating AIoT solutions for custom business requirements are also garnering the market’s success. Also, automation-based research and development facilities are giving the green light to IoT-based industrial manufacturing.

Key Points

  • The United States market leads the market in terms of market share in North America. The United States region held a market share of 20.5% by 2022. The growth in this region is attributed to well-built automated systems and increased industrial automation. North America dominates the IoT in the manufacturing market as it held a 38.5% global share in 2022.
  • Germany’s IoT in manufacturing market is another significant market in the European region. The market held a market share of 12.1% in 2022. The growth is attributed to substantial industrial and automotive manufacturing facilities. Along with the new companies investing in the infrastructure. Europe held a global share of 24.3% in 2022.
  • The Indian IoT in manufacturing market thrives at a CAGR of 15.7% during the forecast period. The booming growth rate is attributed to the growth of IT businesses and outsourcing in India.
  • The discrete manufacturing segment leads the vertical type segment as it held a market share of 57.6% in 2022. The growth is attributed to better efficiency.
  • Based on the application type, the automation control and management segment leads as it held a market share of 19.3% in 2022. The growth is attributed to the tracking properties and faster performance.

Competitive Landscape

The key vendors work on customer services, technological integration, and better productivity. Companies also collaborate to expand their supply chain. Key competitors and also merge, acquire, and partner with other companies to increase their supply chain, and distribution channel.

Key Players

  • Cisco
  • IBM
  • PTC
  • Microsoft
  • Siemens AG
  • GE
  • SAP
  • Huawei
  • ATOS
  • HCL
  • Intel
  • Oracle
  • Schneider Electric
  • Zebra Technologies
  • Software AG
  • Wind River
  • Samsara
  • Telit (United Kingdom)

Recent Market Development

  • IO Has introduced its IoT Suite that acts as a toolbox in the cloud for IoT developers. It provides Bosch’s services like IoT device management, IoT data management, and IoT edge.
  • ATOS has also introduced its smart business enablement with cyber-systems, including IoT platforms and products.

Get Full Report Now:
https://www.futuremarketinsights.com/reports/iot-in-manufacturing-market

Key Segments Covered

By Component:

  • Solution
  • Services

By Solution:

  • Network management
    • Network bandwidth management
    • Network security management
    • Network performance monitoring and management
    • Network configuration management
  • Data management
    • Data integration
    • Data security
    • Data migration
    • Data analytics and visualization
    • Metadata management
    • Data governance
    • Data orchestration
  • Device management
    • Device provisioning and authentication
    • Device configuration management
    • Monitoring and troubleshooting
  • Application management
  • Smart surveillance
    • Central monitoring system
    • Video analytics and events

By Services:

  • Managed services
    • Infrastructure management services
    • Security management services
    • Network management services
    • Data management services
    • Device management services
  • Professional services
    • IoT consulting services
      • Technology consulting services
      • Business consulting services
      • Operational consulting services
    • IoT infrastructure services
      • Network services
      • Deployment services
      • Cloud services
    • System designing and integration services
      • Platform development and integration services
      • Mobile and web application development services
    • Support and maintenance services
    • Education and training services

By Organisation Size:

  • Small and Medium Enterprises
  • Large Enterprises

By Deployment Mode:

  • On-premises
  • Cloud

By Application:

  • Predictive maintenance
  • Business process optimization
  • Asset tracking and management
  • Logistics and supply chain management
  • Real-time workforce tracking and management
  • Automation control and management
  • Emergency and incident management and business communication

By Vertical:

  • Process manufacturing
    • Chemical and materials
    • Food and beverages
    • Water and waste management
    • Other verticals
  • Discrete manufacturing
    • Automotive
    • Machine Manufacturing
    • Semiconductor and electronics
    • Medical devices
    • Logistics and transportation

Key Regions Covered:

  • North America
  • Latin America
  • Europe
  • Japan
  • Asia Pacific Excluding Japan
  • The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Menopause Treatment Industry in India Set for Remarkable Growth, Projected to Reach USD 147.3 Million by 2034

The menopause treatment industry in India is on the brink of substantial growth, with recent projections indicating a robust expansion at a Compound Annual Growth Rate (CAGR) of 6.6% through 2034. According to the latest research, the industry is forecasted to escalate from USD 78.0 million in 2024 to a staggering USD 147.3 million by 2034, marking a significant leap in market value.

This promising upward trajectory follows a notable rise from USD 72.7 million in 2023, with a year-on-year growth of 7.2% expected in 2024 alone. The surge in demand for menopause treatment solutions is attributed to several key factors driving industry expansion.

Get Market Intelligence: Checkout Now to Access

One of the primary drivers is the increasing public awareness of the benefits associated with menopause treatment, coupled with a growing prevalence of menopausal symptoms among women. This heightened awareness is catalyzing a transformative shift in the industry, notably marked by a rising acceptance of hormone replacement therapy (HRT) among women, reflecting evolving health choices and preferences.

Moreover, ongoing clinical trials within India underscore a commitment to pioneering solutions in menopause treatment, addressing current industry needs and fostering a competitive landscape conducive to further innovations.

The burgeoning healthcare infrastructure and a growing emphasis on women’s health are expected to further propel the menopause treatment industry forward. Additionally, there is a rising demand for personalized medicine, which tailors treatment to each patient’s unique needs, further fueling the industry’s growth.

Commenting on the industry’s outlook, a FMI stated, “The projected growth of India’s menopause treatment industry reflects both the evolving healthcare landscape and the increasing prioritization of women’s health issues. As awareness grows and innovative solutions emerge, we anticipate a dynamic and thriving market that continues to meet the diverse needs of women experiencing menopausal transitions.”

The anticipated surge in the menopause treatment industry not only underscores the growing demand for effective solutions but also signifies a significant opportunity for stakeholders to contribute to the advancement of women’s health in India.

The menopause treatment industry in India is experiencing a significant growth trajectory, driven by several key factors:

  • Increase in Drug Development Efforts: The rise in the number of menopausal drugs advancing through development pipelines indicates a promising outlook for the industry. This surge in research and development activities underscores a commitment to addressing the unmet needs of menopausal individuals, fostering a competitive landscape and driving further innovation.
  • Expansion of Treatment Options: The influx of innovative treatments not only fills current gaps in the market but also fosters a competitive environment, encouraging the development of new therapeutic solutions. This expansion of treatment options enhances patient choice and satisfaction, ultimately contributing to industry growth.
  • Focus on Natural and Herbal Remedies: There is a growing interest in exploring natural or herbal treatment options for managing menopausal symptoms. Leading companies in the pharmaceutical sector are capitalizing on this trend by developing evidence-based natural treatments. These alternatives offer the promise of fewer side effects, catering to the increasing demand for holistic and gentle approaches to menopause management.
  • Alignment with Wellness Trends: The emphasis on organic and natural remedies aligns with broader cultural shifts toward wellness and preventive healthcare. Consumers are increasingly inclined to explore alternative treatments that prioritize safety and efficacy. Manufacturers leveraging this trend stand to benefit by developing scientifically validated natural treatments that meet consumer demand.

Overall, the convergence of these factors presents lucrative opportunities for the menopause treatment industry in India. By continuing to invest in research and development, expanding treatment options, and aligning with consumer preferences for natural remedies, companies can capitalize on the growing market demand and drive industry growth.

Get Ahead with Full Report Insights – Access It Now

Key Companies Profiled:

  • Pfizer Inc.
  • Bayer AG
  • Serum Institute of India
  • Intas Pharmaceuticals Limited
  • Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
  • Torrent Pharmaceuticals Ltd.
  • Koye Pharmaceuticals Pvt. Ltd.
  • Emcure Pharmaceuticals
  • Vitabiotics
  • Himalaya Global Holdings Ltd.
  • Nature’s Way Brands
  • Bharat Serums and Vaccines Limited (BSV)
  • Nordic Naturals
  • ZeroHarm

Menopause Treatment Industry Segmentation by Category:

By Product:

  • Hormone Therapy
    • Combination
    • Tibolone
    • Progestin-only Medicines
    • Estrogen-only Medicines
  • Non-hormonal Therapy
    • Gabapentinoids
    • Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
    • Selective Serotonin Reuptake Inhibitors (SSRI)
    • Others
  • Nutritional Supplements
    • Multi-vitamin Supplements
    • Phytoestrogen Supplement
    • Antioxidant Supplements
    • Other Supplements

By Route of Administration:

  • Topical
  • Injectable
  • Oral

By Market Status:

  • Rx
  • OTC

By Distribution Channel:

  • Hospitals
  • Specialty Clinics
  • Retail Pharmacies
  • Drug Stores
  • Online Sales/Online Pharmacy Platforms

By Region:

  • Northern India
  • Northeast India
  • Central India
  • Eastern India
  • Western India
  • Southern India

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube